Rubella, also known as German measles, is a viral infection caused by the rubella virus. The virus primarily spreads through respiratory droplets and is characterized by a mild rash, fever, and lymphadenopathy. While rubella infection is generally mild, its significant impact lies in its potential to cause congenital rubella syndrome (CRS) if contracted by pregnant women, especially during the first trimester. Congenital rubella syndrome is associated with severe birth defects, including deafness, cataracts, heart defects, and intellectual disabilities. The devastating consequences of CRS highlight the importance of preventing rubella in pregnant women through vaccination. The widespread use of the rubella vaccine as part of the measles, mumps, and rubella (MMR) vaccine has led to a significant decline in rubella cases and CRS globally.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Gendered socioeconomic impacts of emerging infectious diseases: Insights from a mixed-methods study in Guinea
Stephanie Maltais, University of Montreal, Canada
Title : The role of social sciences in operationalizing the One Health approach: A case study of the DOPERAUS project in Guinea and the Democratic Republic of Congo
Stephanie Maltais, University of Montreal, Canada